chrisvoncsefalvay/vaers-outcomes huggingface dataset:
diarrhea; felt like flu; achy arm; chills; little fever; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), INFLUENZA LIKE ILLNESS (felt like flu), PAIN IN EXTREMITY (achy arm), CHILLS (chills) and PYREXIA (little fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (diarrhea), INFLUENZA LIKE ILLNESS (felt like flu), PAIN IN EXTREMITY (achy arm), CHILLS (chills) and PYREXIA (little fever). At the time of the report, DIARRHOEA (diarrhea), INFLUENZA LIKE ILLNESS (felt like flu), PAIN IN EXTREMITY (achy arm), CHILLS (chills) and PYREXIA (little fever) outcome was unknown.            Action taken with mRNA-1273 in response to the event was not applicable. No concomitant and treatment information was provided.   Reporter did not allow further contact
This spontaneous report is received from a 32 year old female healthcare worker referring herself. No medical history and drug allergies were reported. On 12-JUL-2013, the healthcare worker cut her finger on a broken VARIVAX (Merck) (Lot # H006462, exp. date: 08-MAR-2014). PQC filled for broken VARIVAX (Merck). The healthcare worker treated the cut "per office protocol". Additional information has been requested.
pain all over my body; pain left arm pit; pain in my left breast; Some chill; very fatigue.; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; (Lot Number: EP6955) via an unspecified route of administration in the arm left on 30Mar2021 at 12:15 (at the age of 46-year-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism. The patient had a history of allergy to penicillin. Concomitant medications included levothyroxine 100mcg (MANUFACTURER UNKNOWN) from unknown date for unknown indication. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247,) via an unspecified route of administration in the arm left on 09Mar2021 at 09:45 (at the age of 46-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 31Mar2021 at 00:15, after 12 hours of the second dose, the patient experienced general body pain, the left arm pit area and left breast  (injection arm) and had 8/10 level of pain, chills and very fatigue. The patient did not received any treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events general body pain, armpit pain, breast pain, chills and fatigue was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
soreness at injection site; redness at the injection site; Hotness at the injection site; swelling at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE DISCOMFORT (soreness at injection site), INJECTION SITE ERYTHEMA (redness at the injection site), INJECTION SITE WARMTH (Hotness at the injection site) and INJECTION SITE SWELLING (swelling at the injection site) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Jan-2021, the patient experienced INJECTION SITE DISCOMFORT (soreness at injection site), INJECTION SITE ERYTHEMA (redness at the injection site), INJECTION SITE WARMTH (Hotness at the injection site) and INJECTION SITE SWELLING (swelling at the injection site). At the time of the report, INJECTION SITE DISCOMFORT (soreness at injection site), INJECTION SITE ERYTHEMA (redness at the injection site), INJECTION SITE WARMTH (Hotness at the injection site) and INJECTION SITE SWELLING (swelling at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  No concomitant medication was provided.
Nausea, vomiting, diarrhea, fever, rash over entire body within 24 hours of receiving the vaccine. Treated with oral steroids. Rash outbreaks continue presently.
Pt c/o dizziness (BP 96/59; HR 78; RR 18). Pt denies chest pain, SOB. Pt stable at time of D/C (BP 104/68; HR 54; RR 17)
symptoms started 12/15. seen and tested positive on 12/16, admitted to hospital on 12/25 requiring high flow O2 decadron, remdesivir and baricitinib started
Patient received first Pfizer dose. During the observation period, patient appeared lethrargic after fiveminutes of sitting. Nurse Practitioner staff observer attending to patient and he stated "I don't feel good". Patient became diaphorectic. He was drinking water. Patient became pale and more lethargic. Team Alert code was call overhead. BP: 61/19. HR: 41. Oxygen Saturation: 98% at room air. Emergency department physician and staff arrived at 5:22pm. Patient was placed on a gurney in Trandelenberg and moved to the Emergency Department for further evaluation.
Migraines for both shots Second shot: Large, rapidly appearing Ganlion cyst in injection arm within 9 days.
indication=Treatment of COVID-19; indication=Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 66 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 20Aug2021 14:00 (Lot number: EW0175) at the age of 66 years as dose 3 (booster), single, administered in arm left, administration date 04Mar2021 13:00 (Lot number: EN6203) as dose 2, single and administered in arm left, administration date 11Feb2021 15:00 (Lot number: EN6201) as dose 1, single for covid-19 immunisation. Relevant medical history included: "RA" (unspecified if ongoing), notes: Verbatim: RA; "Autoimmune hepatitis" (unspecified if ongoing), notes: Verbatim: Autoimmune hepatitis; "NAFL" (unspecified if ongoing), notes: verbatim: NAFL; "Depression" (unspecified if ongoing), notes: Verbatim: Depression. The patient's concomitant medications were not reported. Past drug history included: Enbrel, start date: 09Sep2013, notes: other medication in 2weeks product=Enbrel,, other medication in 2weeks brand= Accredo,, other medication in 2weeks start date=09Sep2013; Cellcept, start date: 06Dec2019, notes: other medication in 2weeks product=Cellcept,, other medication in 2weeks start date=06Dec2019; Levothryoxin, start date: Apr1995, notes: other medication in 2weeks product=Levothryoxin,, other medication in 2weeks start date=Apr1995; Pristiq, start date: May2000, notes: other medication in 2weeks product=Pristiq,, other medication in 2weeks start date=May2000. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "indication=Treatment of COVID-19". Therapeutic measures were taken as a result of suspected covid-19, Anti-viral drug (treatment start date=14Mar2022, lot number=FX2740) used for COVID 19 Treatment.
Injection site was tender to touch 2 days after injection and began itching 3-4 days after.  Patient rubbed and scratched site of itching.  Six days after injection, patient noticed a large circular red area around ijection site was raised(swollen).  Only the outer edge of circle was swollen.
I was sitting down eating lunch at work when I had an onset of heart palpatations. I work at a hospital so my coworker called a code and the rapid response team hooked me up to a monitor and they said it looked like I was in afib. I have a history of SVT but I had an ablation in 2014 and have not had palpatations since until February 15th. 2 weeks after my 2nd COVID vaccine. Not sure if this is related, but I?ve been seeing on the news that there have been heart issues in young adults linked to the vaccine.
7:15PM patient was accompanied by her aunt/guardian. Client?s aunt/guardian completed and signed the COVID-19 consent form.  Client was given a Pfizer COVID-19 vaccine (lot #EW0168 expiration date 8/31/2021) in the right deltoid by RN.  7:25PM Client c/o feeling ?dizzy? and ?hot?. Client was noted leaning forward in the chair. Client denied any chest pain or difficulty swallowing or difficult respirations.  7:27PM client B/P was 80/50; pulse 76 strong and regular; client c/o increased dizziness and feeling ?shaky? with an increase in diaphoresis was noted.  Client was placed in a supine position with feet elevated. 7:30PM 911 call was made by another RN and observation of client continued with no change in condition. 7:37PM Paramedics arrived: Paramedics ran an EKG strip and did a PO2 which was unremarkable. B/P by Paramedics 96/60. Paramedics continued to observe client and did a repeat B/P. 7:41PM Client reports feeling better. Paramedics helped client to a sitting position.  Client sitting B/P 104/64 and blood sugar of 50 (done by Paramedics). Paramedics administered and oral glucose liquid to client. 7:46PM Repeat blood sugar 67 and standing B/P 134/85. Paramedics recommend client?s aunt follow-up with client?s doctor on client?s hypoglycemia. Client told Paramedics she is a dancer and she (client) had an episode of feeling ?dizzy? and ?shaky? last week. Client also reports she ate ?2 hotdogs? prior to coming for COVID 19 vaccine and additionally denies missing meals. RN
Hot feeling at the injection site; Soreness at the injection site; Redness at the injection site; This case was reported by a consumer via call center representative and described the occurrence of injection site warmth in a 61-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 19th August 2020, the patient received the 1st dose of Shingrix (intramuscular). On 19th August 2020, less than a day after receiving Shingrix, the patient experienced injection site warmth, injection site pain and injection site erythema. On an unknown date, the outcome of the injection site warmth, injection site pain and injection site erythema were not recovered/not resolved.   It was unknown if the reporter considered the injection site warmth, injection site pain and injection site erythema to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix in the left arm. The patient experienced after vaccination had redness at the injection site, soreness at the injection site, and a hot feeling at the injection site that were all still ongoing currently. The reporter consent to follow up. This case has been linked with case US2020167496 and US2020167494, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020167496:Mother in law's case US-GLAXOSMITHKLINE-US2020167494:Husband's case
The patient presented to the health clinic on 10/25/21 for a Moderna booster. The RN administered a (.5ml) full dose Moderna vaccine.  The patient was notified of the error and denied any side effects at that time. He was advised to call the health department with any questions or concerns.
I tested positive after using an at-home COVID-19 kit on 05/03/2022. I've had symptoms similar to my seasonal allergy symptoms but a bit more severe. I've suffered from runny nose, cough, fatigue, body aches, fever, and a headache. I went to a pharmacy to complete an antigen test on 05/04/2022, and the results came back positive again for COVID-19. My physician prescribed Paxlovid for a five-day treatment course. The first two days, my symptoms were persistent but mild as the Paxlovid was working. I finished the prescription on 05/09/2022 and currently feeling pretty much better. I still feel more fatigue than normal, but all of my other symptoms have pretty much subsided.
Shaking, chills, fever >100 degrees, site of injection red and sore, some c/o N/V (6 days after administration of Tdap).
NUMBNESS, TINGLING IN EXT. PROGRESSIVELY GETTING WORSE, DECREASED SENSATION, INCONTIENCE OF BOWEL AND BLADDER. AS SX PROGRESSED DIFFICULTY AMBULATING.
Fatigue started at 5 hours post vaccine, continued for 4 days. Headache started 5 hours post vaccine lasted for 12 hours. Fever of 100.7 - 102.3, chills started 12 hours post vaccine and lasted 36 hours.12 hours post vaccine severe muscle and joint pain,  sore throat and congestion. 5 hours post vaccine, injection site started hurting, grew warm and inflamed with a nickel sized red area around injection point that grew over time. At 24 hours was a quarter size, with a hard knot, 36 hours a half dollar in size, 48 hours the size of a lemon, 72 hours a small eggplant. Arm hurt from shoulder joint to elbow. After 4 days, it started to recede. By day 7 redness was gone and arm only ached, though the immediate area around injection site is still numb. Acetaminophen was taken every 8 hours for 3 days to relieve pain and fever. Primary Care Provider Dr. was notified. He said it seemed a normal adverse reaction, but nothing to worry about.
Woke up in June unable to walk, only after extreme difficulty. In pain ever since, all over my body, Very tired all the time. Feet and hands swelling
Fever,chills, body aches, cough, sore throat, headaches, rash at site of injection also swollen and itchy as well.
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. Information regarding relevant medical history and concurrent condition were not reported. On 16-NOV-2015 the patient was vaccinated with MMRII (lot # L012479, expiration date 10-APR-2017, dose and route not reported), which was exposed to temperatures outside of the recommended temperature. No adverse experience had been reported. This is one of several reports received from the same source. Additional information has been requested.
Acute on chronic respiratory failure with hypoxia. What was found was that he is a chronic CO2 retainer so his oxygen was titrated to maintain his oxygen saturations between 88-92%. The most likely etiology of his acute on chronic hypoxic respiratory failure is from his myotonic dystrophy as he already has home NIPPV and has already been prescribed home oxygen but he has not set up his home oxygen. He was then discharged on 4 L of supplemental oxygen via anoxia mask as this helped him maintain oxygen saturations better than the nasal cannula. ED visit to hospital admission within 6 weeks of receiving the COVID vaccine.
The delayed reaction began on March 24, 2021 in the early evening.  My right arm (bicep and injection site area) began to itch and break out in a rash.  I applied over the counter hydrocortisone and took a Chlorpheniramine Maleate 4 mg allergy tablet.  The site continued to itch throughout the night and woke me up several times.  Upon rising on March 25, 2021 I looked at my arm and the top of my shoulder and the rash had spread and there were large red hives that were hot to the touch, itching, swelling, and painful.  I decided it was time to call my Dr. and make an appointment. I was not able to see him and was referred to his colleague.  I went to see her at 11:30 a.m. She diagnosed the rash as a Moderna Delayed Reaction.  She prescribed a prescription strength Hydrocortisone Cream to be applied3 times daily  and Chlorpheniramine Maleate 4 mgs. since I am allergic to Benadryl every four hours. As of today, March 26, 2021 the rash has improved but still has the intense itch that travels down my arm and up.
Within 2 hours of vaccine bad frontal headache and dizziness.  Symptoms have persisted until today- 2 days later
-severe shaking / chills  for 2 hours ...so much so  that I could not get warm and my muscles hurt from shaking so much  -headache, body ache , both 24 hours -soreness at sight of injection
After 10 minutes of vaccination, patient reported to pharmacy that she was not feeling good and assume that her neck was swollen. I check the neck area, no swelling, and asked if she was breathing fine, and patient was ok. I offered to give epi pen in case she is allergic to any, but refused. EMS showed 2 minutes later and took over.
experienced restless leg syndrome for years and she got her 1st dose and last night didn't experience it.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558).  A female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) (Batch/Lot number: unknown) as dose 1, single for COVID-19 immunisation. Relevant medical history included: "restless leg syndrome" (unspecified if ongoing), notes: she experienced restless leg syndrome for years. The patient's concomitant medications were not reported.  The following information was reported: THERAPEUTIC RESPONSE UNEXPECTED (non-serious), outcome "unknown", described as "experienced restless leg syndrome for years and she got her 1st dose and last night didn't experience it.".  Additional information: The patient experienced restless leg syndrome for years and when she got her first dose, and last night (at the time of reporting) she did not experience it.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
UNSTABLE ANGINA 9/13/2021 CAD (CORONARY ARTERY DISEASE) WO ANGINA  ACUTE RESPIRATORY FAILURE 10/28/2021 CAD (CORONARY ARTERY DISEASE) WO ANGINA  ACUTE HYPOXEMIC RESPIRATORY FAILURE 8/6/2021 CAD (CORONARY ARTERY DISEASE) WO ANGINA  CHRONIC RESPIRATORY FAILURE 10/24/2021 CAD (CORONARY ARTERY DISEASE) WO ANGINA  CHRONIC HYPOXEMIC RESPIRATORY FAILURE 10/28/2021 CAD (CORONARY ARTERY DISEASE) WO ANGINA  UNSTABLE ANGINA 9/13/2021 PRESENCE OF TRACHEOSTOMY  ACUTE RESPIRATORY FAILURE 10/28/2021 PRESENCE OF TRACHEOSTOMY  ACUTE HYPOXEMIC RESPIRATORY FAILURE 8/6/2021 PRESENCE OF TRACHEOSTOMY  CHRONIC RESPIRATORY FAILURE 10/24/2021 PRESENCE OF TRACHEOSTOMY  CHRONIC HYPOXEMIC RESPIRATORY FAILURE 10/28/2021 PRESENCE OF TRACHEOSTOMY  UNSTABLE ANGINA 9/13/2021 CAD (CORONARY ARTERY DISEASE) WO ANGINA  ACUTE RESPIRATORY FAILURE 10/28/2021 CAD (CORONARY ARTERY DISEASE) WO ANGINA  ACUTE HYPOXEMIC RESPIRATORY FAILURE 8/6/2021 CAD (CORONARY ARTERY DISEASE) WO ANGINA  CHRONIC RESPIRATORY FAILURE 10/24/2021 CAD (CORONARY ARTERY DISEASE) WO ANGINA  CHRONIC HYPOXEMIC RESPIRATORY FAILURE 10/28/2021 CAD (CORONARY ARTERY DISEASE) WO ANGINA  UNSTABLE ANGINA 9/13/2021 PALLIATIVE CARE  ACUTE RESPIRATORY FAILURE 10/28/2021 PALLIATIVE CARE  ACUTE HYPOXEMIC RESPIRATORY FAILURE 8/6/2021 PALLIATIVE CARE  CHRONIC RESPIRATORY FAILURE 10/24/2021 PALLIATIVE CARE  CHRONIC HYPOXEMIC RESPIRATORY FAILURE 10/28/2021 PALLIATIVE CARE
24 hours after vaccine injection site was red and warm to tough then after 2 days a bruise about the size of an egg above where the injection site appeared
For the 3rd shot (a booster) my armpit really hurts, and my feet/hands are colder then normal
Patient arrived at pharmacy stating his left arm was extremely sore. To the point that he had trouble turning the steering wheel of his car. He took TYLENOL to relieve the pain. The pain has improved somewhat today.
Patient received Moderna vaccine on 7/19/2021.  When entering the information in VacTrak it was discovered that the patient had received Janssen vaccine on 4/23/2021. No adverse signs or symtptoms noted by the patient.  Patient notified of the event.
This case was reported by a physician via call center representative and described the occurrence of migraine in a 60-year-old female patient who received SHINGRIX for prophylaxis. On 1st February 2019, the patient received SHINGRIX (intramuscular). On 8th February 2019, 7 days after receiving SHINGRIX, the patient experienced migraine. On 8th February 2019, the outcome of the migraine was recovered/resolved. It was unknown if the reporter considered the migraine to be related to SHINGRIX. Additional details were provided as follows: The health care professional reported that the patient received SHINGRIX vaccine in left deltoid and developed migraine 7 days later. Emergency room visit required. The event resolved now. The reporter did not consent to follow up.
Headache; This is a spontaneous report from a contactable consumer (patient)via Pfizer Sponsored Program. A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on an unspecified date at single dose for COVID-19 immunization.  The patient medical history and concomitant medications were not reported.  The patient experienced headache on an unspecified date with outcome of unknown.  Information on the lot/batch number has been requested.
Feeling hot at site; Swelling at site going down to left arm and to elbow; delayed injection site itchiness; delayed injection site redness; COVID Arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (COVID Arm), VACCINATION SITE WARMTH (Feeling hot at site), PERIPHERAL SWELLING (Swelling at site going down to left arm and to elbow), VACCINATION SITE PRURITUS (delayed injection site itchiness) and VACCINATION SITE ERYTHEMA (delayed injection site redness) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy (Rash, hives as a baby) since 1956.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced VACCINATION COMPLICATION (COVID Arm), PERIPHERAL SWELLING (Swelling at site going down to left arm and to elbow), VACCINATION SITE PRURITUS (delayed injection site itchiness) and VACCINATION SITE ERYTHEMA (delayed injection site redness). On an unknown date, the patient experienced VACCINATION SITE WARMTH (Feeling hot at site). On 20-Mar-2021, PERIPHERAL SWELLING (Swelling at site going down to left arm and to elbow), VACCINATION SITE PRURITUS (delayed injection site itchiness) and VACCINATION SITE ERYTHEMA (delayed injection site redness) had resolved. At the time of the report, VACCINATION COMPLICATION (COVID Arm) and VACCINATION SITE WARMTH (Feeling hot at site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided.   No treatment details pertained to the events were provided.  The patient wanted to know if she could take Benadryl to lessen the side effects after second dose.   This case was linked to MOD-2021-114276.   Most recent FOLLOW-UP information incorporated above includes: On 12-Aug-2021: Significant follow up received. Events are updated i.e., Vaccine complication, Vaccine site warmth, peripheral swelling.
pt recv vax & 24NOV97 pt devel small pinpoint papules w/hive like areas around ankles;